Back to Journals » Oncolytic Virotherapy

Oncolytic Virotherapy

ISSN: 2253-1572

Editor-in-Chief: Dr Faris Farassati

An international, peer-reviewed, open access online journal publishing original research, study protocols, reviews, editorials and commentaries on all aspects of oncolytic virology, namely the application of oncolytic viruses for the treatment of cancer.

This journal is a member of and subscribes to the principles of the Committee on Publication Ethics (COPE).

Latest articles:

- 5 records -

The Current State of Oncolytic Herpes Simplex Virus for Glioblastoma Treatment

Nguyen HM, Saha D

Oncolytic Virotherapy 2021, 10:1-27

Published Date: 24 February 2021

Treatment of an Alveolar Rhabdomyosarcoma Allograft with Recombinant Myxoma Virus and Oclacitinib

Ashton LV, Graham B, Afzali MF, Gustafson D, MacNeill AL

Oncolytic Virotherapy 2020, 9:17-29

Published Date: 26 May 2020

Virus–Receptor Interactions and Virus Neutralization: Insights for Oncolytic Virus Development

Jayawardena N, Poirier JT, Burga LN, Bostina M

Oncolytic Virotherapy 2020, 9:1-15

Published Date: 6 March 2020

Impact of Induced Syncytia Formation on the Oncolytic Potential of Myxoma Virus

Burton C, Bartee MY, Bartee E

Oncolytic Virotherapy 2019, 8:57-69

Published Date: 9 December 2019

Virus–Receptor Interactions: Structural Insights For Oncolytic Virus Development

Jayawardena N, Burga LN, Poirier JT, Bostina M

Oncolytic Virotherapy 2019, 8:39-56

Published Date: 29 October 2019

Read more articles